Roche: EUA for cobas MPXV test in US

(CercleFinance.com) - Roche announces that the US FDA has granted an Emergency Use Authorization (EUA) for cobas MPXV, a real-time PCR assay for the qualitative detection of simian orthopoxvirosis virus DNA, for use on cobas 6800/8800 systems.


This high-throughput test for simian orthopoxvirosis virus (MPXV) becomes the first to receive an EUA following evaluation on real patient samples, rather than just laboratory-formulated samples.

High-throughput solutions enable rapid results, enabling individuals to avoid additional testing or unnecessary isolation, and facilitating access to appropriate treatment as soon as possible, the Swiss healthcare group said.


Copyright (c) 2022 CercleFinance.com. All rights reserved.